Nishi Kothari

559 total citations
29 papers, 372 citations indexed

About

Nishi Kothari is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nishi Kothari has authored 29 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Nishi Kothari's work include Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Genomics and Diagnostics (4 papers). Nishi Kothari is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Genomics and Diagnostics (4 papers). Nishi Kothari collaborates with scholars based in United States, Australia and United Kingdom. Nishi Kothari's co-authors include Richard D. Kim, Amit Mahipal, Shilpa Gupta, Khaldoun Almhanna, David Shibata, Jamie K. Teer, Muhammad Wasif Saif, Damon R. Reed, Sean Yoder and Yonghong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Nishi Kothari

29 papers receiving 371 citations

Peers

Nishi Kothari

ONCOL

PRM

SURGE

Maria Alessandra Calegari Italy

Shota Fujimoto Japan

Liisa Chang United Kingdom

Aiwen Wu China

Ignazio Martellucci Italy

Longgang Cui China

Inge Ubink Netherlands

Chester Kao United States

Enrique Sanz‐García Spain

Maria Alessandra Calegari Italy

Nishi Kothari

220 ×0.9

ONCOL

109 ×0.7

PRM

89 ×1.0

70 ×0.9

56 ×0.8

SURGE

Citations per year, relative to Nishi Kothari Nishi Kothari (= 1×) peers Maria Alessandra Calegari

Countries citing papers authored by Nishi Kothari

Since Specialization

Citations

This map shows the geographic impact of Nishi Kothari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishi Kothari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishi Kothari more than expected).

Fields of papers citing papers by Nishi Kothari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nishi Kothari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishi Kothari. The network helps show where Nishi Kothari may publish in the future.

Co-authorship network of co-authors of Nishi Kothari

This figure shows the co-authorship network connecting the top 25 collaborators of Nishi Kothari. A scholar is included among the top collaborators of Nishi Kothari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nishi Kothari. Nishi Kothari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2023). S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES. HemaSphere. 7(S3). e37234fb–e37234fb. 7 indexed citations

N., Kim, Dana E. Rathkopf, Gerhardt Attard, et al.. (2020). A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641).. Journal of Clinical Oncology. 38(6_suppl). TPS257–TPS257. 1 indexed citations

Kim, Dae Won, et al.. (2017). EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience. Oncology. 92(4). 190–196. 17 indexed citations

Kothari, Nishi & Daniel A. Anaya. (2017). Multidisciplinary Management of Rectal Cancer with Synchronous Resectable Liver Metastases. Current Colorectal Cancer Reports. 13(1). 1–9. 1 indexed citations

Saeed, Nadia, Eric A. Mellon, Kenneth Meredith, et al.. (2017). Adjuvant chemotherapy and outcomes in esophageal carcinoma.. Journal of Clinical Oncology. 35(4_suppl). 181–181. 2 indexed citations

Saeed, Nadia, Eric A. Mellon, Kenneth Meredith, et al.. (2017). Adjuvant chemotherapy and outcomes in esophageal carcinoma. Journal of Gastrointestinal Oncology. 8(5). 816–824. 15 indexed citations

Kothari, Nishi, Eric A. Mellon, Sarah E. Hoffe, et al.. (2016). Outcomes in patients with brain metastasis from esophageal carcinoma. Journal of Gastrointestinal Oncology. 7(4). 562–569. 17 indexed citations

Soares, Heloisa P., Nishi Kothari, Amit Mahipal, et al.. (2016). Multi-institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.. Journal of Clinical Oncology. 34(4_suppl). TPS468–TPS468. 4 indexed citations

Kothari, Nishi, Jamie K. Teer, Yonghong Zhang, et al.. (2016). Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers. Cancer. 122(18). 2828–2835. 45 indexed citations

10.

Abuodeh, Y.A., Sarah E. Hoffe, Jessica M. Frakes, et al.. (2016). Impact of sarcopenia evaluated using the total psoas area (TPA) in patients undergoing Y-90 radioembolization for hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 34(4_suppl). 217–217. 2 indexed citations

11.

Soares, Heloisa P., et al.. (2016). An investigator sponsored phase Ia/Ib trial of selinexor in combination with irinotecan in patients with adenocarcinoma of stomach and distal esophagus.. Journal of Clinical Oncology. 34(4_suppl). TPS176–TPS176. 2 indexed citations

12.

Kim, Richard D., Nishi Kothari, Mokenge P. Malafa, et al.. (2015). PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer. Clinical Nuclear Medicine. 40(11). e501–e505. 27 indexed citations

13.

Kothari, Nishi, Binglin Yue, Jamie K. Teer, Michael J. Schell, & Richard D. Kim. (2015). Prognostic and predictive values of APC and WNT pathway mutations in MSS colorectal cancers.. Journal of Clinical Oncology. 33(3_suppl). 652–652. 1 indexed citations

14.

Kothari, Nishi & Khaldoun Almhanna. (2015). Current status of novel agents in advanced gastroesophageal adenocarcinoma.. PubMed. 6(1). 60–74. 18 indexed citations

15.

Kothari, Nishi, Richard D. Kim, Gregory M. Springett, et al.. (2015). Surgery and adjuvant therapy in gallbladder cancer: A single-institution experience.. Journal of Clinical Oncology. 33(3_suppl). 405–405. 2 indexed citations

16.

Kothari, Nishi, Michael J. Schell, Jamie K. Teer, et al.. (2014). Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing. Journal of Clinical Pathology. 67(9). 764–767. 22 indexed citations

17.

Kothari, Nishi, et al.. (2014). Predictive Biomarkers for Anti-Epidermal Growth Factor Receptor Therapy: BeyondKRASTesting. Journal of the National Comprehensive Cancer Network. 12(10). 1433–1442. 5 indexed citations

18.

Kothari, Nishi, Richard D. Kim, Peter Gibbs, et al.. (2014). Regular aspirin (ASA) use and survival in patients with PIK3CA-mutated metastatic colorectal cancer (CRC).. Journal of Clinical Oncology. 32(3_suppl). 386–386. 4 indexed citations

19.

Kothari, Nishi, Timothy J. Yeatman, Kate Fisher, Michael J. Schell, & Richard D. Kim. (2013). Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation.. Journal of Clinical Oncology. 31(15_suppl). 3644–3644. 1 indexed citations

20.

Kothari, Nishi, Muhammad Wasif Saif, & Richard D. Kim. (2013). First-Line Treatment for Advanced Pancreatic Cancer. PubMed. 14(2). 129–32. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact